T
he Centers for Disease Control and Prevention 1 estimates that 1.7 million nosocomial infections occurred in the United States in 2002. ICUs had the highest rates of infection, at 13 per 1,000 patientdays, and mortality, ranging from 11% for surgical site infection (SSI) to 25% for bloodstream infection (BSI). 1 The most common ICU infections are pneumonia, urinary tract infection (UTI), and BSI, 2 and are usually device related. The rate of device-related ICU infections has decreased during the last 25 years (Fig 1) . [3] [4] [5] [6] The US government is providing new incentives for further improvement. The Centers for Medicare and Medicaid Services will stop reimbursing hospitals for care made necessary by eight preventable complications as of October 1, 2008 . 7 Two of these are ICU complications: vascular catheter-related BSI and catheter-associated UTI. Other ICU infections are expected to follow, such as ventilator-associated pneumonia (VAP) and methicillin-resistant Staphylococcus aureus infection.
The need for improvement has generated many articles on ICU infections, 8 -13 including the excellent review by Eggimann and Pittet, 13 and evidencebased guidelines. 14 -20 Many of these guidelines will be updated in 2008, so they are summarized only briefly in this review. Observational studies confirm that evidence-based approaches can reduce infection 21 Analyses of studies showed that bundled interventions were even more effective and reduced rates of catheter-related BSI by a range of 29 to 95% 22 and VAP by 31 to 57%. 23 Management guru Peter Drucker conceptualized management by objectives Ͼ 50 years ago 24 and advocated the use of specific, measurable, achievable, relevant, and time-bound (SMART) objectives. The purpose of this review is to summarize recent studies of preventive interventions in the ICU, with the aim of identifying SMART objectives to further reduce the infection rate. A PubMed search was conducted to identify observational studies of bundled interventions that aimed to prevent nosocomial infections; studies published since the year 2000 were selected whenever possible.
No decision has been made unless carrying it out in specific steps has become someone's work assignment and responsibility.
Peter F. Drucker, management guru Intravascular Catheter-Related BSI The Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines 14 for preventing intravascular-catheter-related BSI include educating health-care workers, assessing their knowledge of and adherence to guidelines, and using designated, trained personnel to insert and maintain catheters ( Table 1 ). The guidelines also include routine monitoring to determine infection rates in patients with central venous catheters (CVCs), trends in those rates, and lapses in infection-control practices. 14 Surveillance should include a written plan, maintaining intensity and consistency over time, adequate personnel and other resources, and annual evaluation. 25 Prospective observational studies 26 -32 confirm that bundled interventions can significantly reduce infection rates (Table 2) . Success rates, however, are highly variable depending on institution-specific factors, such as the baseline infection rate, preventive tactics chosen for bundles, and adherence to the tactics. Success rates also vary depending on study design, especially duration of observation, as well as many other variables.
My colleagues conducted a series of studies 26 -28 14 Category IA ϭ strongly recommended for implementation and strongly supported by well-designed studies.
risk-reduction tactics focused on methods for the following: (1) hand hygiene and aseptic technique; (2) detecting signs and symptoms of infection; (3) sending catheter-tip culture; (4) catheter-site care; (5) replacing administration sets and fluids; (6) caring for injection ports and dead-end caps; (7) handling parenteral fluids and multidose vials; and (8) drawing blood cultures. This educational intervention was directed at surgical ICU nurses and decreased the rate of CVC-related infections by 66% (p Ͻ 0.0001). 26 The number of infections fell to none the second month after intervention, but this level of success was not sustainable over the 18-month postintervention period. Random bedside audits revealed multiple adherence deficiencies, 27 the most common being failure to date the dressing (nonadherence rate, 89%) and improper hand hygiene (83%). Next, my colleagues 27 designed behavioral interventions for nurses and physicians, which generally improved adherence and led to a nonsignificant trend toward a further decrease in infection rate.
In our third study, 28 the educational intervention was expanded to include physicians and provide monthly feedback on infection rates to ICU staff. This bundled approach decreased the CVC-related infection rate by 42% (p ϭ 0.019). As in the previous study, 26 the early zero infection rate was not sustainable throughout the 24-month postintervention period, 28 underscoring the need for achievable objectives. For example, Bhutta and colleagues 30 aimed to reduce infection rates below the national rate by the year 2000. They formed a multidisciplinary team to implement evidence-based tactics in a stepwise manner. The overall relative RR of 75% (p Ͻ 0.001) met their predefined objective. 30 Eggimann and colleagues 29 reported a sustained reduction for 6 years after implementing a bundled approach. Adherence may have been improved by involving staff members in program design and requiring training for new nurses, residents, and fellows. 29 Three studies confirmed success across multiple institutions. In Pennsylvania, 31 an advisory committee of regional infection-control experts discussed strategies and collaborated with infection-control professionals and medical staff at participating hospitals. This bundle reduced the mean infection rate by 68% over 4 years. 31 In Michigan, 32 each ICU designated physician and nurse team leaders who partnered with local infection-control practitioners to implement interventions and monitor infection rates. The evidence-based procedures were similar to those in the Pennsylvania study and also included hand hygiene. This bundled intervention significantly reduced the infection rate at 3 months and sustained it for 18 months. 32 In a multistate study, 33 Hand hygiene is a seemingly simple practice that merits consideration because of the impact on CVCassociated BSIs 34 and low staff adherence rate of only 40%. 35 Coopersmith 27 was shocked that none of five physicians washed their hands or used alcohol foam before inserting CVCs. Simply disseminating hand hygiene guidelines does not change practice; bundled approaches are more likely to be effective. 34 Bhutta et al 30 first attempted to improve adherence with annual campaigns that included posters, hospital television video, before and after intervention testing, and newsletters. To further facilitate hand washing, his institution quadrupled the number of hand-washing stations per bed and added two alcohol-gel stations per bed. Collectively, these tactics increased adherence to hand hygiene from 47 to 82%. 30 These practices are generally consistent with HICPAC hand-washing guidelines, which address educational and motivational programs, administrative measures, selection of hand-washing agents, and other aspects of hand hygiene. 35 Adequacy of staffing and other resources also merit consideration because of the impact on CVC-related BSI 36, 37 and other nosocomial ICU infections. [38] [39] [40] For example, the patient-to-nurse ratio was an independent risk factor for CVC-related BSI in the surgical ICU, suggesting that staff reductions contributed to an outbreak of BSIs by impeding adequate catheter care during increased use of total parenteral nutrition. 36 Novel tactics are being evaluated for added benefit to bundles. 41 For example, antiseptic-or antibiotic-impregnated catheters and antisepticimpregnated dressings may be useful because these tactics mitigate any adherence problems for busy ICU staff, especially when target infection rates cannot be achieved. Minocycline-and rifampin-impregnated catheters were the second step implemented by Bhutta and colleagues. 30 Each step appeared to further reduce the infection rate; however, the incremental benefit of these catheters was not specified. 30 Vancomycin lock solution was beneficial in high-risk patients (risk ratio, 0.34; 95% CI, 0.12 to 0.98; p ϭ 0.04) in a metaanalysis of seven studies 42 ; however, studies are needed to assess the impact on resistance. Staphylococcus aureus conjugate vaccine conferred partial immunity against S aureus bacteremia in a double-blind study 43 of patients undergoing hemodialysis (estimate of efficacy, 57%; 95% CI, 10 to 81%; p ϭ 0.02), but the benefit waned after 40 weeks. A sutureless device for securing peripherally inserted CVCs reduced the infection rate in a randomized comparison with sutures (infection rate, 2% vs 12%; p ϭ 0.032), 44 but larger studies are needed to confirm these findings.
The things included in the measurement become relevant; the things omitted are out of sight and out of mind.
Peter F. Drucker
VAP
The American Thoracic Society, 15 Joint Planning Group 16 and HICPAC 17 rate their recommendations on the strength of supporting evidence (Table 3) . These guidelines are based on VAP pathogenesis 8, 45 and aim to prevent bacterial colonization of the aerodigestive tract (eg, routine hand hygiene between patient contacts) and aspiration (eg, continuous aspiration of subglottic secretions and semirecumbent positioning of the patient). Nonadherence is common among physicians 46, 47 and nurses, 48 and does not correlate with the level of evidence. [47] [48] [49] Among physicians, the most common reasons for nonadherence are disagreement with interpretation of clinical studies (35%), lack of resources (31%), and costs (17%). 47 Among nurses, the most common reasons are lack of resources (37%), miscellaneous (overwork, lack of time for hand washing; 22%), patient discomfort (8%), disagreement with reported study results (8%), and fear of potential adverse events (6%). 48 In another survey, 50 nurses perceived that the main determinant of semirecumbency was physicians' orders, whereas intensivists perceived that the main determinant was nursing preference. These heterogeneous factors should be considered in designing educational approaches.
Prospective observational studies [51] [52] [53] confirm that educational interventions can encourage bundled practices, which in turn can significantly reduce infection rates (Table 4) . For example, my colleagues 52 conducted a series of studies, first at our adult teaching hospital 51 and subsequently at three additional local hospitals. Specific risk-reduction tac-tics included meticulous hand hygiene, semirecumbent positioning (Ն 30°), oral intubation, and regularly draining condensate from ventilator circuits. This intervention decreased VAP rates by 58% at the teaching hospital (p Ͻ 0.001) 51 and 46% at all four hospitals (p Ͻ 0.001). 52 Decreases were significant at each hospital, except for one community hospital where respiratory therapists had the lowest educational module completion rate (p Ͻ 0.001), suggesting the importance of adherence to educational tactics. Lai and colleagues 53 assembled a team at the University of Massachusetts Medical Center to outline and implement tactics in a stepwise manner.
Steps focused on respiratory therapists and ICU nurses who received quarterly feedback on VAP rates. Diagnosing physicians were not aware of the intervention, potentially limiting bias. Each step further reduced VAP rates, for overall reductions of 38% (surgical ICU) and 48% (medical ICU). 53 Novel tactics are being evaluated for added benefit to bundles. For example, a silver-coated endotracheal tube (ETT) is promising because it is the first tactic to become user independent after intubation, circumventing the dual problems of adherence and workload. Clinical benefit was demonstrated in a multicenter, randomized, controlled study. 54 In patients intubated Ն 24 h, the silver-coated ETT was associated with reduced rates of microbiologically confirmed VAP at any time after intubation (rate for silver vs uncoated, 4.8% vs 7.5%; RR reduction, 35.9%; p ϭ 0.03) and within 10 days of intubation (rate, 3.5% vs 6.7%; RR reduction, 47.6%; p ϭ 0.005). The device appeared to confer additional benefit because participating institutions followed local preventive practices and avoided change during the study. There were no between-group differences in frequency and severity of adverse events. 54 Subglottic secretion drainage reduced the incidence of VAP by nearly half (relative ratio, 0.51; 95% CI, 0.37 to 0.71) in a metaanalysis. 55 The benefit occurred in patients expected to require Ͼ 72 h of mechanical ventilation and was primarily attributable to reduced incidence of early onset pneumonia. Subglottic secretion drainage is associated with few complications, except for case reports of tracheal mucosal injury, 56 and anecdotal reports of plugging of the specialized lumen for aspiration of secretions. 55 Can we achieve this idea? Or can we only talk about it?
Peter F. Drucker UTI HICPAC guidelines 18 for preventing catheterassociated UTI were published in 1981 (Table 5 ) and are currently under revision. Current category 1 recommendations include educating staff about correct aseptic catheter insertion and care techniques, hand washing before and after catheter manipulation, maintaining a closed system, properly securing catheters, and maintaining unobstructed urine flow. A practice to be avoided in ICUs is routine use of prophylactic antibiotics. 57 Prospective observational studies 58, 59 confirm that preventive interventions can significantly reduce catheter-associated UTI rates (Table 6 ). For example, Goetz and colleagues 58 reported that simply providing nurses with unit-specific quarterly feedback on infection rates reduced them by 46% (p ϭ 0.002). Rosenthal and colleagues 59 implemented a bundle that led to an RR reduction of 0.58 (95% CI, 0.39 to 0.86; p ϭ 0.006). 59 Novel tactics should be considered for added benefit to bundles. For example, silver alloy-coated urinary catheters have been studied extensively and shown to significantly reduce catheter-associated UTI rates in metaanalyses. 60, 61 Only two studies 62, 63 have focused specifically on the ICU, and trends favoring silver-coated catheters were not significant. Nonetheless, urinary catheters are used widely across the entire inpatient setting (ICU and non- There is nothing so useless as doing efficiently that which is irrelevant.
SSI
Extensive guidelines are available from the Centers for Disease Control and Prevention for preventing SSI, from before to after operative care (Table  7) . 19 For example, antimicrobial prophylaxis should be used only when indicated and based on the most common pathogens for the specific operation and published guidelines. The drug should be administered IV to yield bactericidal concentrations during the surgical procedure. 19 Specifically, dosing should begin 60 min before incision, 64 and end Յ 48 h after cardiac surgery 65 and Յ 24 h after other surgeries. 64 One of the most ICU-relevant guidelines involves postoperative incision care, specifying sterile dressing for 24 to 48 h after primary closure, and hand washing before and after any surgical-site contact. 19 Prospective observational studies 66 -68 confirm that preventive interventions can significantly reduce SSI rates (Table 8) . For example, Geubbels and colleagues 67 reported success with a national surveillance network in the Netherlands that enabled hospitals to compare rates and optimize infectioncontrol practices. The adjusted risk of infection was reduced by 31% during the fourth year (95% CI, 11 to 46%) and 57% during the fifth year (95% CI, 24 to 76%). 67 Dellinger and colleagues 68 reported success with a 1-year collaborative project in which teams of clinical champions (eg, surgeon and infectioncontrol professional) attended sessions on implementing and measuring change. Multiple types of communication facilitated exchange of innovations, barriers, lessons learned, and results. The infection rate was reduced by 27% from the first to the last quarter (p ϭ 0.0005). 68 Time is the scarcest resource and unless it is managed, nothing else can be managed.
Peter F. Drucker

CLOSTRIDIUM DIFFICILE-Associated Diarrhea
C difficile is the most common cause of nosocomial diarrhea, 20 an increasingly common ICU problem. When the Society of Healthcare Epidemiology of America published its 1995 position paper, 20 the only guidelines supported by good evidence were using gloves to handle body substances, using disposable thermometers during outbreaks, and antimicrobial stewardship. Studies conducted since 1995 support additional practices aiming at the following: (1) to prevent ingestion of C difficile through environmental control, staff hygiene, and barrier precautions; and (2) to reduce the risk of infection after ingestion, primarily through antimicrobial stewardship. 69 Tactics to be avoided include antimicrobial prophylaxis and treating asymptomatic carriers. 69 Popular hospital cleaning agents and alcoholbased hand sanitizers are ineffective against C difficile. The preferred alternatives are hypochlorite solution (1:10 mixture of household bleach to water) for environmental disinfection and either soap or chlorhexidine for hand hygiene. 69 When the rate of C difficile-associated diarrhea increased from 5.3 to 16.6 cases per 1,000 patient-days in a medical ICU at my institution, 70 we implemented intensive entireunit environmental cleaning; daily cleaning of the nursing station, staff restroom, staff conference room, and waiting room; twice-daily cleaning of patient-care equipment; and monthly infection-rate reports. This bundle reduced the rate to 3.7 cases per 1,000 patient-days (RR, 0.22; 95% CI, 0.09 to 0.56). Next, we simplified the intervention and cleaned infected patient rooms daily, sustaining the reduction for 2 years (RR, 0.17; 95% CI, 0.9 to 0.32). This simpler approach successfully controlled a surgical-ICU outbreak and sustained it for 2 years (RR, 0.22; 95% CI, 0.09 to 0.52). 70 Muto and colleagues 71 recently reported success with a series of practices that were fine tuned following surveillance. The first three had little impact. The next practice was more successful and focused on cleaning patient rooms. Subsequent practices included the following: (1) hand washing with soap and water, (2) infection-control audits, and (3) restricting use of clindamycin, ceftriaxone, and levofloxacin. Collectively, these practices reduced the annual infection rate per 1,000 patient-days from 10.4 in 2000 to 3.0 in 2006 (odds ratio, 3.5; 95% CI, 2.3 to 5.4; p Ͻ 0.001). 71 Probiotics are viable microorganisms that colonize the GI tract and are an attractive option because of ease of administration, low cost, and safety profile. 72 In a metaanalysis, 73 probiotics reduced the RR of antibiotic-associated diarrhea (RR, 0.43; 95% CI, 0.31 to 0.58; p Ͻ 0.001), but only 13 of 25 randomized, blinded studies had significant between-group differences favoring probiotics. These conflicting results may be attributable to study population differences; concomitant antibiotic use; and probiotic type, dose, and duration. Well-designed multicenter studies are needed to determine the role of probiotics in preventing C difficile-associated diarrhea in the ICU. 72 
Conclusions
Evidence-based guidelines are available to reduce nosocomial ICU infection rates, especially when simple tactics are bundled. To increase the likelihood of success, follow the SMART approach. Choose specific objectives that precisely define and quantify desired outcomes, such as reducing the nosocomial ICU infection rate of an institution by 25%. Avoid unrealistic objectives, such as attempting to completely eliminate nosocomial infections. To measure the objective, monitor both staff adherence to tactics and the infection rate using predefined criteria, and provide feedback to ICU staff. Make objectives achievable and relevant by engaging stakeholders and empowering them to select specific tactics and steps for implementation. Nurses and other stakeholders are in the best position to identify the preventive tactics that are achievable within their busy ICUs. Begin with simple, cost-effective tactics. Anticipate the need to add more tactics to achieve the desired target infection rate; specify which tactics will be added to the bundle, and when and how they will be added. Unburden the bedside provider by taking advantage of new technologies shown to reduce nosocomial infection rates. Objectives should also be relevant to the institution so that administrators provide adequate staffing and other resources. Appoint a team to champion the intervention and collaborate with administrators and ICU staff. Provide ongoing communication to reinforce educational tactics and fine-tune practices over time. Make objectives time bound; set dates for collecting baseline and periodic data, and a completion date for evaluating the success of the intervention.
